Analyst firms · Argus Research · CHWY
Argus Research CHWY price target and rating history
Chewy Inc. (CHWY) · Consumer Discretionary
Argus Research rates Chewy Inc. (CHWY) Buy with a $30 price target, as of its latest action on Jan 23, 2025. It has published 4 rating actions on CHWY since April 2023, including 2 upgrades and 1 downgrade. Across 4 firms with a CHWY price target in the last 12 months, the median target is $25.
- Current rating
- Buy
- Price target
- $30
- Median target, all firms
- $25
- Actions on CHWY
- 4
Every Argus Research rating on CHWY
- Jan 23, 2025
- Jul 9, 2024
- Sep 6, 2023
- Apr 19, 2023
How other firms rate CHWY
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Stifel | Hold | $22 | Nov 17, 2026 |
| Evercore ISI | In-line | $25 | Sep 10, 2026 |
| Rosenblatt | Neutral | $25 | Aug 20, 2026 |
| MoffettNathanson | Neutral | Jun 11, 2026 | |
| Raymond James | Outperform | $28 | Feb 19, 2026 |
Questions about Argus Research and CHWY
- What is Argus Research's price target for CHWY?
- Argus Research's latest stated price target for Chewy Inc. (CHWY) is $30, from its action on Sep 6, 2023.
- What is Argus Research's rating on CHWY?
- Argus Research rates CHWY Buy, a bullish rating, as of Jan 23, 2025.
- When did Argus Research last change its view on CHWY?
- On Jan 23, 2025, Argus Research upgrades to Buy from Hold.
- How does Argus Research's CHWY target compare with other analysts?
- Across 4 firms with a CHWY price target in the last 12 months, the median target is $25.
More CHWY rating histories
- Evercore ISI3
- MoffettNathanson3
- Raymond James3
- Deutsche Bank3
- Mizuho4
- Jefferies4
- Wolfe Research4
- BNP Paribas Exane3
- Citigroup3
- Needham4
- Piper Sandler4
- Barclays4
- Goldman Sachs4
- Morgan Stanley4
- UBS3
- Oppenheimer3
- Robert W. Baird3
- Wedbush5
All Argus Research ratingsCHWY news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.